Acorah Software Products - Accounts Production 15.0.600 false true 30 June 2023 1 July 2022 false true No description of principal activity 1 July 2023 30 June 2024 30 June 2024 11423056 Dr G Lymperopoulos iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11423056 2023-06-30 11423056 2024-06-30 11423056 2023-07-01 2024-06-30 11423056 frs-core:CurrentFinancialInstruments 2024-06-30 11423056 frs-bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 11423056 frs-bus:FilletedAccounts 2023-07-01 2024-06-30 11423056 frs-bus:Micro-entities 2023-07-01 2024-06-30 11423056 frs-bus:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 11423056 frs-bus:Director1 2023-07-01 2024-06-30 11423056 2022-06-30 11423056 2023-06-30 11423056 2022-07-01 2023-06-30 11423056 frs-core:CurrentFinancialInstruments 2023-06-30
Registered number: 11423056
GL Medical Ltd
Financial Statements
For The Year Ended 30 June 2024
Balance Sheet
Registered number: 11423056
2024 2023
£ £
Current assets 96,352 64,358
Creditors: Amounts Falling Due Within One Year (17,739 ) (14,221 )
NET CURRENT ASSETS 78,613 50,137
TOTAL ASSETS LESS CURRENT LIABILITIES 78,613 50,137
NET ASSETS 78,613 50,137
CAPITAL AND RESERVES 78,613 50,137

Notes

1. General Information
GL Medical Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 11423056 . The registered office is Suite G First Floor Offices, 230 High Street, Potters Bar, Hertfordshire, EN6 5BL.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
For the year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr G Lymperopoulos
Director
15/08/2024